We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $-0.26 | — | — | $156.35M | — | Scheduled |
| FY2024 Q3 | 2023. 06. 30. | Time TBD | — | — | — | — | $115.89M | Reported |
| FY2024 Q2 | 2023. 03. 31. | Time TBD | — | — | — | — | $70.37M | Reported |
| FY2024 Q1 | 2022. 12. 31. | Time TBD | — | — | — | — | $27.82M | Reported |
Consensus PT $20.38 · 12 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 14. | Macquarie | — | Maintain | Outperform → Outperform | — | Macquarie: Outperform |
| 2026. 05. 13. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
Compare a firm's past rating changes and its actions on other stocks in the same sector.